SomaLogic to Participate in the Jefferies Healthcare Conference

BOULDER, Colo., May 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that the company will be participating in the upcoming Jefferies Healthcare Conference.

SomaLogic management is scheduled to participate in a fireside chat on Wednesday, June 7, 2023, at 3:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the virtual session on the “Investors” section of the company’s website at: https://investors.somalogic.com/events-and-presentations.

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.

SomaLogic Contact
Emilia Costales
720-798-5054
[email protected]

Investor Contact
Marissa Bych
Gilmartin Group LLC
[email protected]

You May Also Be Interested In

• International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
• BREAKING NEWS: ELEKTROS Enters the Investor Spotlight as Growing Market Awareness Highlights Its Sierra Leone Hard-Rock Lithium Vision and Proprietary EV Charging Technology
• The 16th Worldwide Chinese Life Insurance Congress & 2026 International Dragon Award (IDA) Annual Conference Grandly Held